Viramal   Report issue

For profit Phase 1 Phase 2
Founded: London United States (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2017
NCT03352076
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Viramal Limited

Active Ingredients

Drugs in Phase 2 Trials (1)

danazol (danocrine) (1 trial)

Drugs in Phase 1 Trials (1)

estradiol (progynon depot) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endometriosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2